Publication: Dual-layered and double-targeted nanogold based lateral flow immunoassay for influenza virus
Issued Date
2015-01-01
Resource Type
ISSN
14365073
00263672
00263672
Other identifier(s)
2-s2.0-84927519075
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Microchimica Acta. Vol.182, No.1-2 (2015), 85-93
Suggested Citation
Natpapas Wiriyachaiporn, Weerakanya Maneeprakorn, Chayachon Apiwat, Tararaj Dharakul Dual-layered and double-targeted nanogold based lateral flow immunoassay for influenza virus. Microchimica Acta. Vol.182, No.1-2 (2015), 85-93. doi:10.1007/s00604-014-1303-9 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35775
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Dual-layered and double-targeted nanogold based lateral flow immunoassay for influenza virus
Other Contributor(s)
Abstract
© Springer-Verlag Wien 2014. We report on a highly sensitive lateral flow immunoassay (LFIA) for influenza A which serves as a model antigen. Gold nanoparticles conjugated to monoclonal antibodies specific to the two most abundant influenza A proteins, nucleoprotein and matrix protein, were used as detector probes. Using this approach, the nucleoprotein and matrix protein in the virion were detected simultaneously. The signal was further amplified via a signal amplification strategy that is making use of two-layered nanogold in combination with a double-targeted detection format. Under optimized conditions, the system is capable of detecting influenza A antigens in infected cells at levels as low as 47 TCID50·mL−1(50 % tissue culture infectious dose) within 15 min. Compared to the conventional LFIA based on single-targeted detection, the detection capability of this system is better by a factor of 8 without requiring additional steps or instruments. In addition to its simplicity and rapidity, this LFIA also can detect the target analyte in even complex biological matrix. This proofof- principle of a dual-layered and double-targeted nanogoldbased LFIA is deemed to be useful for developing single-step, rapid, and sensitive tests for screening and diagnosis.
